Off Label Marketing

Learn about the controversial practice of off label marketing, where pharmaceutical companies promote the use of drugs for unapproved purposes. John Abramson shares his firsthand experience with Pfizer's off label marketing of Neurontin, revealing the lack of evidence and the impact on public health.